Kyndryl Faces Securities Lawsuit Following Control Deficiencies Disclosure

GlobeNewswire Inc.GlobeNewswire Inc.
|||1 min read
Key Takeaway

Kyndryl faces securities lawsuit after disclosing internal control weaknesses and delayed 10-Q filing. Stock dropped 21.8% following CFO and General Counsel departures.

Kyndryl Faces Securities Lawsuit Following Control Deficiencies Disclosure

Kyndryl Holdings, Inc. is the subject of an ongoing securities class action lawsuit stemming from a February 9, 2026 disclosure that revealed the company would be unable to file its Form 10-Q on schedule due to material weaknesses in internal controls. The announcement also included the departure of both the company's Chief Financial Officer and General Counsel, triggering significant market reaction.

Following the disclosure, Kyndryl's stock price declined substantially, falling $2.31 per share from $10.59 to an intraday low, representing approximately a 21.8% single-day decline. Investors who experienced losses exceeding $100,000 during the relevant period are eligible to participate in the class action litigation and have been notified of a lead plaintiff application deadline set for April 13, 2026.

The lawsuit represents a coordinated effort by affected shareholders to seek recovery related to the securities disclosure and its market impact. Institutional investors and individual shareholders meeting the financial threshold for participation have been advised to review their eligibility and submit documentation within the specified timeframe. The case remains in its preliminary phases as it moves through the class action certification process.

Source: GlobeNewswire Inc.

Back to newsPublished Feb 26

Related Coverage

GlobeNewswire Inc.

uniQure, Gartner Face Securities Fraud Suits Over Material Disclosure Failures

Law firm files class actions against uniQure, Gartner, and Trip.com for alleged failure to disclose material information. Stock declines range from 19% to 49%.

QUREITTCOM
GlobeNewswire Inc.

Trip.com Faces Securities Fraud Lawsuit After Antitrust Probe, Stock Slides 19%

Trip.com faces securities fraud lawsuit after Chinese antitrust probe alleges monopolistic practices; stock fell 19.4%. Investors have until May 11, 2026 to file claims.

TCOM
GlobeNewswire Inc.

Gartner Faces Securities Fraud Suit After 48% Stock Plunge on Guidance Miss

Gartner faces securities fraud suit after 48% stock decline linked to reduced guidance. Investors can apply as lead plaintiffs through Kahn Swick & Foti, LLC.

QURETCOM
GlobeNewswire Inc.

Driven Brands Faces Securities Fraud Suit Over Misstated Financials, Stock Plummets 39%

Driven Brands Holdings faces securities fraud class action over undisclosed financial statement errors spanning 2023-2025, triggering a 39% stock decline.

QUREDRVNTCOM
GlobeNewswire Inc.

Apollo Global Management Hit with Securities Fraud Suit Over Epstein Ties, 16% Stock Plunge

Apollo Global Management faces securities fraud class action over undisclosed Epstein communications. Stock fell 16% during class period; investors can file claims by May 1, 2026.

APOAPOSAPOpA
GlobeNewswire Inc.

Corcept Therapeutics Faces Securities Fraud Suit Over Undisclosed FDA Setback

Class action lawsuit filed against Corcept Therapeutics alleging securities fraud tied to FDA rejection of relacorilant, triggering 50% stock plunge.

CORTQURETCOM